amrinone has been researched along with Cardiac Septal Defect in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"With this dosage regimen, amrinone provides a higher cardiac output, more favorable oxygen dynamics, and lower pulmonary vascular resistance than dopamine and nitroglycerin." | 2.68 | Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. ( Happonen, JM; Korpela, R; Laitinen, P; Leijala, M; Peltola, K; Rautiainen, P; Sairanen, H, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laitinen, P | 1 |
Happonen, JM | 1 |
Sairanen, H | 1 |
Peltola, K | 1 |
Rautiainen, P | 1 |
Korpela, R | 1 |
Leijala, M | 1 |
1 trial available for amrinone and Cardiac Septal Defect
Article | Year |
---|---|
Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect.
Topics: Amrinone; Dopamine; Double-Blind Method; Female; Heart Septal Defects; Hemodynamics; Humans; Infant; | 1997 |